Sapna Srivastava Talaris Therapeutics, Inc. (TALS) insider trading activity

Sapna Srivastava is Director of Talaris Therapeutics, Inc.. Currently has a direct ownership of 518 shares of TALS, which is worth approximately $1,408. The most recent transaction as insider was on Oct 19, 2023, when has been sold 518 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 518

0% 3M change

0% 12M change

Total Value Held $1,408

Sapna Srivastava Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 19 2023	BUY Grant, award, or other acquisition	-	518 Added 50.0%	518 Common Stock

Also insider at

SQZ

SQZ Biotechnologies Co Healthcare

Director

NUVL

Nuvalent, Inc. Healthcare

AURA

Aura Biosciences, Inc. Healthcare

INVA

Innoviva, Inc. Healthcare

Director

ALMS

ALUMIS INC.